EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparative analysis of lipid profile changes in treatment-naïve people living with HIV on INSTI-based single-tablet regimens, BIC/FTC/TAF and DTG/3TC: real-world evidence from South Korea

So Yun Lim, BumSik Chin iD, Min-Kyung Kim, Gayeon Kim, Yeonjae Kim

Journal of Antimicrobial Chemotherapy · 2025

DOI: 10.1093/jac/dkaf213 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2025. Verfasst von So Yun Lim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: HIV Infections, Anti-HIV Agents, Lipids. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advances in antiretroviral therapy (ART) have shifted the focus of HIV management towards metabolic comorbidities such as atherosclerotic cardiovascular disease (ASCVD). However, real-world data comparing lipid profile changes, key determinants of ASCVD, between bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir/lamivudine (DTG/3TC) remain limited.

Methods

A retrospective cohort study was conducted using medical records from the National Medical Center, Seoul, South Korea, from January 2012 to March 2024. Lipid profiles were analysed over 2 years following initiation of BIC/FTC/TAF or DTG/3TC in treatment-naïve people living with HIV (PLH). Individuals receiving lipid-lowering agents and a previous history of ASCVD were excluded. People with hepatitis B and/or C virus infection were included, and infection status was adjusted for as a covariate along with alanine aminotransferase and aspartate aminotransferase. A linear mixed model was applied to compare lipid profiles between the different ART regimens over time.

Results

A total of 194 treatment-naïve PLH were included in the final analysis: 137 (70.6%) initiated BIC/FTC/TAF and 57 (29.4%) initiated DTG/3TC. Over 2 years, longitudinal analysis showed that PLH receiving DTG/3TC had significantly smaller LDL cholesterol increases over time compared to BIC/FTC/TAF (ART-by-time interaction: β = −8.03, P = 0.035). The TC/HDL-C ratio showed a trend towards improvement in the DTG/3TC group (β = −0.19, P = 0.094). Triglyceride levels remained stable with no significant ART-by-time interaction (β = 17.60, P = 0.271).

Conclusions

DTG/3TC demonstrated more favourable lipid changes than BIC/FTC/TAF in treatment-naïve individuals, with significantly smaller LDL cholesterol increases and a trend towards an improved TC/HDL ratio over time. These findings may be informative during the ART selection especially for PLH with cardiovascular risk factors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV InfectionsAnti-HIV AgentsLipidsHumansRetrospective StudiesMaleFemaleMiddle AgedRepublic of KoreaAdultLamivudinePiperazinesTenofovirEmtricitabinePyridonesOxazinesDrug CombinationsHeterocyclic Compounds, 3-RingDolutegravir

Substanzen

Anti-HIV AgentsLipidsLamivudinePiperazinesTenofovirEmtricitabinePyridonesOxazinesDrug CombinationsHeterocyclic Compounds, 3-Ring

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, National Medical Center, Seoul, Republic of Korea.
  • Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: BumSik Chin

Zitieren

APA

Lim, S. Y., Chin, B., Kim, M. K., Kim, G., & Kim, Y. (2025). Comparative analysis of lipid profile changes in treatment-naïve people living with HIV on INSTI-based single-tablet regimens, BIC/FTC/TAF and DTG/3TC: real-world evidence from South Korea. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf213

Vancouver

Lim SY, Chin B, Kim MK, Kim G, Kim Y. Comparative analysis of lipid profile changes in treatment-naïve people living with HIV on INSTI-based single-tablet regimens, BIC/FTC/TAF and DTG/3TC: real-world evidence from South Korea. Journal of Antimicrobial Chemotherapy. 2025. doi:10.1093/jac/dkaf213

BibTeX
@article{Lim2025,
  author = {Lim, So Yun and Chin, BumSik and Kim, Min-Kyung and Kim, Gayeon and Kim, Yeonjae},
  title = {Comparative analysis of lipid profile changes in treatment-naïve people living with HIV on INSTI-based single-tablet regimens, BIC/FTC/TAF and DTG/3TC: real-world evidence from South Korea},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  doi = {10.1093/jac/dkaf213}
}
Kostenlos starten →